Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$152M |
| 2 |
AT&T
T
|
+$119M |
| 3 |
Norfolk Southern
NSC
|
+$117M |
| 4 |
CSX Corp
CSX
|
+$115M |
| 5 |
Booking.com
BKNG
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$156M |
| 3 |
C.H. Robinson
CHRW
|
+$134M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$130M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.4% |
| 2 | Industrials | 9.75% |
| 3 | Financials | 7.9% |
| 4 | Consumer Staples | 7.89% |
| 5 | Healthcare | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPL
701
DELISTED
Buckeye Partners, L.P.
BPL
| $1.94M | 0.01% |
+28,600
| New | +$1.75M |
|
|
SNBR
702
DELISTED
Sleep Number
SNBR
| $1.94M | 0.01% |
+100,000
| New | +$1.91M |
|
|
TMX
703
DELISTED
Terminix Global Holdings, Inc.
TMX
| $1.92M | 0.01% |
75,994
-23,888
| -24% | -$611K |
|
|
BCRH
704
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
| $1.87M | 0.01% |
104,603
| – | – |
|
|
CAB
705
DELISTED
Cabela's Inc
CAB
| $1.85M | 0.01% |
38,051
+15,534
| +69% | +$697K |
|
|
VTAE
706
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $1.85M | 0.01% |
279,156
+163,356
| +141% | +$1.49M |
|
|
AMRN
707
Amarin Corp
AMRN
$292M
| $1.84M | 0.01% |
60,000
-45,518
| -43% | -$1.35M |
|
708
Arista Networks
ANET
$237B
| $1.82M | 0.01% |
462,400
+177,904
| +63% | +$696K |
|
|
FNSR
709
CALL
DELISTED
Finisar Corp
FNSR
| $1.82M | 0.01% |
+100,000
| New | +$1.44M |
|
710
CALL
Incyte
INCY
$25.9B
| $1.81M | 0.01% |
+25,000
| New | +$1.86M |
|
711
Huntington Ingalls Industries
HII
$11.6B
| $1.8M | 0.01% |
13,114
+9,235
| +238% | +$1.2M |
|
712
Boot Barn
BOOT
$4.9B
| $1.76M | 0.01% |
+187,090
| New | +$1.67M |
|
|
ARMH
713
PUT
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $1.75M | 0.01% |
+40,000
| New | +$1.67M |
|
714
Fidelity National Financial
FNF
$12.7B
| $1.75M | 0.01% |
74,188
+63,774
| +612% | +$1.43M |
|
715
Tenaris
TS
$27B
| $1.73M | 0.01% |
+70,000
| New | +$1.53M |
|
|
SYT
716
DELISTED
Syngenta Ag
SYT
| $1.72M | 0.01% |
20,800
+16,691
| +406% | +$1.31M |
|
717
Citigroup
C
$221B
| $1.67M | 0.01% |
+40,065
| New | +$1.67M |
|
718
TransUnion
TRU
$16.3B
| $1.66M | 0.01% |
+60,000
| New | +$1.52M |
|
719
PPG Industries
PPG
$25.2B
| $1.66M | 0.01% |
+14,847
| New | +$1.46M |
|
|
RDUS
720
DELISTED
Radius Health, Inc.
RDUS
| $1.65M | 0.01% |
52,500
| – | – |
|
721
CALL
Universal Display
OLED
$3.89B
| $1.62M | 0.01% |
+30,000
| New | +$1.47M |
|
|
FOLD
722
DELISTED
Amicus Therapeutics
FOLD
| $1.61M | 0.01% |
+190,044
| New | +$1.35M |
|
|
BID
723
PUT
DELISTED
Sotheby's
BID
| $1.6M | 0.01% |
+60,000
| New | +$1.44M |
|
724
CALL
Synaptics
SYNA
$3.66B
| $1.59M | 0.01% |
+20,000
| New | +$1.52M |
|
725
CALL
Applied Materials
AMAT
$384B
| $1.59M | 0.01% |
+75,000
| New | +$1.37M |
|
Similar funds
Dmitry Balyasny's Q1 2016 Portfolio in Review
As of Q1 2016, Dmitry Balyasny held 1,764 positions worth $16.8B, up 17% from $14.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Dmitry Balyasny deployed $2.2B of net new capital in Q1 2016, opening 564 new positions and adding to 341 existing holdings. Its largest new stake was Norfolk Southern: 1,546,641 shares worth $129M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $187M trimmed.
- Dmitry Balyasny's largest Q1 2016 buy was Norfolk Southern: 1,546,641 shares worth $129M.
- Dmitry Balyasny added most to Marathon Petroleum in Q1 2016, an estimated $152M increase.
- Dmitry Balyasny's biggest Q1 2016 reduction was Teva Pharmaceuticals, cutting an estimated $187M.
- Dmitry Balyasny fully exited Union Pacific in Q1 2016, selling an estimated $79.7M.
- Dmitry Balyasny's ten largest holdings make up 12% of its $16.8B portfolio in Q1 2016.
- Dmitry Balyasny opened 564 new positions and closed 526 in Q1 2016.
- Dmitry Balyasny's portfolio value rose 17% quarter-over-quarter to $16.8B.
Based on Balyasny Asset Management's 13F filing for Q1 2016, filed 16 May 2016.